You have full access to this article via your institution. ICRF 159, the drug referred to in Hellmann's correspondence, is antimetastatic but not antiangiogenic. He states that treatment with ICRF 159 ...
We collected a unique pair of microRNA sequencing data sets for the same set of tumor samples; one data set was collected with and the other without uniform handling and balanced design. The former ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback